The fully linked HTML version of this article has now been published.
JCS ePress
online publication date 27 Feb 2007
doi: 10.1242/jcs.002212
Research Article
The ADMA/DDAH pathway is a critical regulator of endothelial cell motility
Beata Wojciak-Stothard*,
Belen Torondel,
Lillian Yen Fen Tsang,
Ingrid Fleming,
Beate Fisslthaler,
James M. Leiper,
and
Patrick Vallance
* Author for correspondence (e-mail: B.Wojciak-Stothard{at}ucl.ac.uk)
Asymmetric dimethylarginine (ADMA) is an inhibitor of nitric oxide production associated with abnormal blood vessel growth and repair, however, the mechanism of action of ADMA is not well understood. We studied the role of exogenous and endogenous ADMA in the regulation of cell motility and actin cytoskeleton in porcine pulmonary endothelial cells (PAECs) and pulmonary microvascular endothelial cells (PMECs) from knockout mice that lack one of the enzyme metabolising ADMA, dimethylarginine dimethylaminohydrolase I (DDAHI) as well as endothelial cells overexpressing DDAH in vitro.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
G. M. Tozer, V. E. Prise, G. Lewis, S. Xie, I. Wilson, and S. A. Hill
Nitric Oxide Synthase Inhibition Enhances the Tumor Vascular-Damaging Effects of Combretastatin A-4 3-O-Phosphate at Clinically Relevant Doses
Clin. Cancer Res.,
June 1, 2009;
15(11):
3781 - 3790.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. G. Zhou, M. Zhou, F. F. Hou, and X. Peng
Asymmetrical dimethylarginine triggers lipolysis and inflammatory response via induction of endoplasmic reticulum stress in cultured adipocytes
Am J Physiol Endocrinol Metab,
April 1, 2009;
296(4):
E869 - E878.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Wojciak-Stothard, B. Torondel, L. Zhao, T. Renne, and J. M. Leiper
Modulation of Rac1 Activity by ADMA/DDAH Regulates Pulmonary Endothelial Barrier Function
Mol. Biol. Cell,
January 1, 2009;
20(1):
33 - 42.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. A. Benndorf, E. Schwedhelm, A. Gnann, R. Taheri, G. Kom, M. Didie, A. Steenpass, S. Ergun, and R. H. Boger
Isoprostanes Inhibit Vascular Endothelial Growth Factor-Induced Endothelial Cell Migration, Tube Formation, and Cardiac Vessel Sprouting In Vitro, As Well As Angiogenesis In Vivo via Activation of the Thromboxane A2 Receptor: A Potential Link Between Oxidative Stress and Impaired Angiogenesis
Circ. Res.,
October 24, 2008;
103(9):
1037 - 1046.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B Wojciak-Stothard
New drug targets for pulmonary hypertension: Rho GTPases in pulmonary vascular remodelling
Postgrad. Med. J.,
July 1, 2008;
84(993):
348 - 353.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Palm, M. L. Onozato, Z. Luo, and C. S. Wilcox
Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems
Am J Physiol Heart Circ Physiol,
December 1, 2007;
293(6):
H3227 - H3245.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Pope, L. Druhan, J. E. Guzman, S. P. Forbes, V. Murugesan, D. Lu, Y. Xia, L. G. Chicoine, N. L. Parinandi, and A. J. Cardounel
Role of DDAH-1 in lipid peroxidation product-mediated inhibition of endothelial NO generation
Am J Physiol Cell Physiol,
November 1, 2007;
293(5):
C1679 - C1686.
[Abstract]
[Full Text]
[PDF]
|
 |
|
© The Company of Biologists Ltd 2007